Reductions In King Wholesale Inventory Drive Q2 Branded Pharma Sales
This article was originally published in The Pink Sheet Daily
Executive Summary
King Pharmaceuticals is attributing a rebound in branded pharmaceutical sales during the second quarter in part to lower wholesaler inventories
You may also be interested in...
King's Inventory Still Too High, But Firm Blames Wholesaler Reporting
Fourth quarter sales of Altace and Skelaxin were adversely affected.
King's Inventory Still Too High, But Firm Blames Wholesaler Reporting
Fourth quarter sales of Altace and Skelaxin were adversely affected.
King Lowers Sonata Forecast, Citing Increased Competitive Activity
King takes $126.9 mil. charge in the second quarter related to Sonata; quarterly sales of the sleep aid are up due to inventory reductions.